Pharmafile Logo
Pharmafocus logo
Advanced Search

GlaxoSmithKline

Showing 15 posts of 164 posts found.

GSK-funded project will print APIs onto tablets

June 14, 2010
Manufacturing and Production, Research and Development GlaxoSmithKline, manufacturing, production, tablets

Researchers at GlaxoSmithKline and two UK universities are working on a technology that could allow active pharmaceutical ingredients to be …

News
Laboratorios Phoenix

GSK acquires Argentine pharma firm

June 11, 2010
Sales and Marketing Argentina, GlaxoSmithKline, Latin America, em

GlaxoSmithKline has acquired a leading Argentine pharma firm Laboratorios Phoenix in a move to make further inroads into Latin America. …

News

GSK signs RNA therapeutics alliance

March 31, 2010
Research and Development GlaxoSmithKline, Isis, RNA

GlaxoSmithKline has forged a new strategic alliance with Isis Pharmaceuticals to exploit the specialist company’s expertise in anti-RNA therapeutics. California-based …

News

Emma Walmsley to head up GSK consumer healthcare

March 23, 2010
Sales and Marketing GlaxoSmithKline, appointment, consumer healthcare, sales and marketing

GlaxoSmithKline has appointed Emma Walmsley president, Consumer Healthcare Europe and president designate, Worldwide Consumer Healthcare with effect from 1 May. …

Appointment

GSK’s Relovair moves into phase III

March 19, 2010
Research and Development GlaxoSmithKline, Relovair, Seretide, Theravance, respiratory

GlaxoSmithKline has started phase III asthma trials of Relovair, the respiratory treatment it is developing with San Francisco biopharma firm …

News

Revolade gets European go ahead

March 15, 2010
Sales and Marketing GlaxoSmithKline, Revolade, thrombocytopenia

European regulators have approved GlaxoSmithKline’s Revolade to treat reduced platelet count in patients with a rare blood disorder. Revolade (eltrombopag) …

News
GSKstephenne

GSK promotes Jean Stephenne to chairman, biologicals

March 15, 2010
Research and Development, Sales and Marketing GlaxoSmithKline, appointment, research and development, sales and marketing

GlaxoSmithKline has appointed Jean Stephenne chairman of GSK Biologicals, the company’s global vaccines division.He is currently president and general manager of …

Appointment

GSK expands inflammatory alliance

March 12, 2010
Research and Development Cellzome, GlaxoSmithKline, rheumatoid arthritis

GlaxoSmithKline has formed a second strategic alliance with Cellzome to research new treatments for inflammatory diseases. GSK will buy into …

News
Worker protest

GSK Italy workers protest site closure

March 10, 2010
Research and Development GlaxoSmithKline, Italy, job cuts

Workers at a GlaxoSmithKline R&D facility in Verona, Italy, have taken to the streets to protest a decision to close …

News
DConnelly

GSK’s Deidre Connelly named Woman of the Year

February 25, 2010
Sales and Marketing GlaxoSmithKline, HBA, appointment, sales and marketing

The Healthcare Businesswomen’s Association has named Deidre Connelly its 2010 Woman of the Year. Connelly is president of North America …

Appointment
Avandia

Reports raise fresh Avandia safety questions

February 23, 2010
Research and Development, Sales and Marketing Avandia, GlaxoSmithKline, diabetes

GlaxoSmithKline’s troubled diabetes drug Avandia has been hit by fresh reports from the US that it increases the risk of …

News
GSKAdrian

GSK appoints Adrian Hodges

February 16, 2010
Sales and Marketing GlaxoSmithKline, appointment, industry reputation, sales and marketing

GlaxoSmithKline has appointed Adrian Hodges to head up corporate responsibility and community partnerships. He moves to the pharma company after …

Appointment

GSK to downsize Harlow R&D site

February 10, 2010
Research and Development GlaxoSmithKline, job cuts

GlaxoSmithKline is on the point of making the first job cuts in a round of redundancies designed to save £500 …

News

GSK appoints Philippe Fauchet president of GSK Japan

February 8, 2010
Sales and Marketing GlaxoSmithKline, appointment, sales and marketing

GSK has appointed Philippe Fauchet president of GSK Japan, reporting to to Marc Dunoyer who takes a new role as …

Appointment

GSK looks to rare diseases research

February 5, 2010
Research and Development GlaxoSmithKline, Orphan

GlaxoSmithKline has launched a new specialist unit to research and develop medicines for rare diseases. The company has identified 5,500 …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026